Cord Blood Controversy: When Profit Trumps Patient Care A recent order by a Punjab district consumer commission has shed light on the disturbing practice of exploiting vulnerable parents seeking to preserve their newborn's cord blood for future medical use in India.
The case involves Cordlife Sciences India, which was directed to pay over Rs 2. 16 lakh to a couple after it discarded their child's umbilical cord blood sample due to alleged delay in payment.
The incident raises serious questions about the ethics of private companies operating in the healthcare sector.